SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-19-005445
Filing Date
2019-08-13
Accepted
2019-08-13 09:01:08
Documents
35
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_081319.htm 10-Q 208495
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8177
3 EXHIBIT 31.2 exh_312.htm EX-31.2 8193
4 EXHIBIT 32 exh_32.htm EX-32 3719
  Complete submission text file 0001171843-19-005445.txt   1949433

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE caps-20190630.xml EX-101.INS 267321
6 XBRL SCHEMA FILE caps-20190630.xsd EX-101.SCH 26050
7 XBRL CALCULATION FILE caps-20190630_cal.xml EX-101.CAL 22398
8 XBRL DEFINITION FILE caps-20190630_def.xml EX-101.DEF 88851
9 XBRL LABEL FILE caps-20190630_lab.xml EX-101.LAB 183816
10 XBRL PRESENTATION FILE caps-20190630_pre.xml EX-101.PRE 168757
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21214 | Film No.: 191018361
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences